There are currently 13.7 million cancer survivors in the U.S., and that number is expected to rise to 18 million by 2022, according to the American Association for Cancer Research’s “Annual Report on Cancer Survivorship in the United States.”

Advanced Medical Isotope Corporation (AMIC) has entered into a strategic alliance with GSG International to collaborate in the joint development of technologies for the production of medical isotopes and the marketing and distribution of related isotopes, equipment and services.

The Optima MR360 Advance and Brivo MR355 Inspire, two 1.5T MR scanners from GE Healthcare, have received 510(k) clearance.

Research published this week demonstrated MRI’s potential in two mysterious and devastating illnesses as well as ongoing concerns with inappropriate use.

The short-term prognostic benefit of myocardial perfusion scintography (MPS) is well established, and the technique also delivers long-term value up to five years after initial imaging, according to a study in the Journal of Nuclear Cardiology. 

A tablet-based testing system may soon be able to listen to a voice of an individual—a football player, for instance—and by analyzing speech patterns, determine whether the person has suffered a concussion, according to researchers at the University of Notre Dame in South Bend, Ind.

Patients with advanced education showing early signs of Alzheimer’s disease (AD) were found to be less vulnerable to neural damage associated with the disease, according to a review in the March publication of Neurology.

 A March 22 teleconference between the Society of Nuclear Medicine and Molecular Imaging (SNMMI), Alzheimer's Association and other stakeholders discussed new appropriate use recommendations concerning amyloid imaging for the evaluation of Alzheimer's disease to be reviewed by CMS.